Psychiatry and Neurology, Neurology · Kearney, NE
NPI
1487637229
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3219 Central Ave
Kearney, NE, 68847
Phone (308) 865-2808
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
480 services
Medicare patients, 2024
210
Average age 68
Drug cost, 2024
$2.0M
4,254 prescriptions
Company payments, 2025
$446
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jan Weber was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 193 times for 160 patients. In total Jan Weber billed 480 services in 13 codes, and Medicare paid $21K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 193 | 160 | $10.65 | $2,055 |
| 99214 Office E&M - Established | Facility | 133 | 119 | $60.45 | $8,040 |
| 99215 Office E&M - Established | Facility | 65 | 56 | $94.07 | $6,115 |
| 95816 Neurologic | Facility | 14 | 14 | $35.63 | $499 |
| 99205 Office E&M - New | Facility | 14 | 14 | $94.25 | $1,320 |
| 99213 Office E&M - Established | Facility | 14 | 14 | $48.09 | $673 |
By year: 2022 $28K for 447 services; 2023 $21K for 366 services; 2024 $21K for 480 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jan Weber prescribed most often to Medicare patients was Gabapentin, with 227 prescriptions and refills. In total Jan Weber wrote 4,254 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 227 | 336 | 36 | $9,908 |
| Levetiracetam Generic | 225 | 270 | 24 | $8,906 |
| Topiramate Generic | 215 | 297 | 32 | $2,069 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 167 | 276 | 31 | $4,643 |
| Carbamazepine Er Carbamazepine | 158 | 183 | 11 | $14K |
| Divalproex Sodium Er Divalproex Sodium | 153 | 163 | 13 | $11K |
| Lacosamide Generic | 126 | 134 | Under 11 | $24K |
| Zonisamide Generic | 122 | 156 | 12 | $2,755 |
| Ropinirole Hcl Generic | 121 | 209 | 27 | $2,417 |
| Primidone Generic | 120 | 161 | 19 | $4,112 |
| Baclofen Generic | 119 | 187 | 21 | $6,719 |
| Teriflunomide Generic | 104 | 130 | 12 | $356K |
| Divalproex Sodium Generic | 98 | 137 | 15 | $6,860 |
| Phenytoin Sodium Extended Generic | 96 | 125 | Under 11 | $2,412 |
| Mirtazapine Generic | 82 | 126 | 17 | $992 |
Brand drugs: 342 claims; generic drugs: 3,846 claims; opioid claims: 89.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jan Weber $446 ($446 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $172 |
| Eisai Inc. 4523.T | 2 | $45.13 |
| SK Life Science, Inc. | 1 | $24.54 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $24.43 |
| Genentech USA, Inc. ROG.SW | 1 | $24.03 |
| TG Therapeutics, Inc. TGTX | 1 | $23.96 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $21.91 |
| Kyowa Kirin, Inc. 4151.T | 1 | $19.62 |
| Celgene Corporation BMY | 1 | $17.69 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $17.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.